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Background: Numerous studies have shown sex differences in the onset and severity of hypertension. Despite
these sex-differences the majority of animal studies are carried out in males. This study investigated expression
changes in both male and female hypertensive mouse kidneys to identify common mechanisms that may be
involved in the development of hypertension.
Methods: The Schlager hypertensive mouse model (BPH/2J) and its normotensive control (BPN/3J) were used in
this study. Radiotelemetry was performed on 12 to 13 week old BPH/2J and BPN/3J male and female animals.
Affymetrix GeneChip Mouse Gene 1.0 ST Arrays were performed in kidney tissue from 12 week old BPH/2J and
BPN/3J male and female mice (n = 6/group). Genes that were differentially expressed in both male and female
datasets were validated using qPCR.
Results: Systolic arterial pressure and heart rate was significantly higher in BPH/2J mice compared with BPN/3J
mice in both males and females. Microarray analysis identified 153 differentially expressed genes that were
common between males and females (70 upregulated and 83 downregulated). We validated 15 genes by qPCR.
Genes involved in sympathetic activity (Hdc, Cndp2), vascular ageing (Edn3), and telomere maintenance (Mcm6)
were identified as being differentially expressed between BPH/2J and BPN/3J comparisons. Many of these genes
also exhibited expression differences between males and females within a strain.
Conclusions: This study utilised data from both male and female animals to identify a number of genes that may
be involved in the development of hypertension. We show that female data can be used to refine candidate genes
and pathways, as well as highlight potential mechanisms to explain the differences in prevalence and severity of
disease between men and women.
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Essential hypertension is a leading cause of morbidity
and mortality worldwide. Risk factors for the development
of hypertension include a combination of environmental
lifestyle factors as well as genetic factors. Significant sex
differences in incidence and severity have long been rec-
ognized in the prevalence of hypertension [1]. These dif-
ferences between males and females have suggested that
the pathogenesis of human hypertension is modified by
sex. The underlying mechanism that leads to disease may
however be common to both sexes. The majority of stud-
ies utilising animal models of disease are carried out in* Correspondence: c.chiu@uws.edu.au
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The Schlager hypertensive mouse model, (BPH/2J) and
its normotensive control (BPN/3J) are a model of spon-
taneous hypertension that were derived via selective
breeding for high and normal blood pressure. The BPH/2J
strain mimics human disease with elevated blood pressure,
increased heart rate, and early mortality. Previous studies
have investigated gene expression changes in BPH/2J and
BPN/3J male mice [2,3]. One study identified expression
changes during early and established hypertension in the
hypothalamus [2]. At both time points, genes involved in
inflammation and oxidative stress were identified as being
differentially expressed between BPH/2J and BPN/3J ani-
mals. Puig et al. compared gene expression in kidney,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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the BPL/1 J (low blood pressure) strains. They identified
222 transcripts that were differentially expressed across all
tissues with expression changes in the same direction [3].
Whether genes and pathways with altered expression in
male hypertensive mice are also altered in female mice, re-
mains to be determined.
In the current study we performed gene expression ar-
rays in kidney tissue from male and female BPH/2J and
BPN/3J mice. We compared gene expression profiles be-
tween BPH/2J and BPN/3J strains, and identified genes
that were common to both sexes. Focusing on biological
processes common to both males and females will help
to refine the mechanisms that are involved in the devel-
opment of hypertension.Methods
Blood pressure measurements
This study involved Schlager BPH/2J and BPN/3J mice.
Previous radiotelemetry studies on 18 to 20 week old
males have shown that blood pressure of BPH/2J hyper-
tensive mice is consistently high and BPN/3J mice is
consistently normal [4]. In this study, radiotelemetry was
performed on 12 to 13 week old male (BPN/3J n = 8,
BPH/2J n = 6) and female (BPN/3J n = 3, BPH/2J n = 4)
mice as previously described [4,5]. In brief, blood pres-
sure telemetry transmitters were implanted, and 10 days
after surgery recordings of systolic arterial pressure were
obtained. This had the Alfred Medical Research Education
Precinct Animal Ethics Committee approval.Tissue collection
To avoid introducing gene expression changes due to
stress handling from blood pressure measurement, blood
pressure was not directly measured in the animals used
for the microarrays. Kidney tissue was collected from
12 week old male and female hypertensive BPH/2J and
age-matched normotensive BPN/3J mice (n = 6/group)
during the inactive period, which corresponds to the
trough in diurnal blood pressure. Mice were eutha-
nized via cervical dislocation and tissues were snap
frozen in liquid nitrogen and stored at -80°C. This study
had University of Western Sydney Animal Ethics Commit-
tee approval.RNA extraction
Tissues were mechanically disrupted in the deep frozen
state as previously described [6]. Total RNA was ex-
tracted from frozen tissue using the Qiagen RNeasy Mini
Kit (Qiagen, Germany) according to the manufacturer’s
recommendations, quantified using the NanoPhotometer
(Implen, Germany) and stored at −80°C.Microarray analysis
RNA quality assessment and microarrays were performed
by the Ramaciotti Centre for Gene Function Analysis,
University of New South Wales, Australia. RNA quality
was confirmed based on a RNA integrity number >8 using
an electrophoresis bioanalyzer (2100 Agilent Bioanalyzer)
and Affymetrix GeneChip Mouse Gene 1.0 ST Arrays
were used. Microarray results were normalised using ro-
bust multiarray analysis (RMA). Differentially expressed
genes between hypertensive and normotensive mice were
identified using GenePattern 3.1 Comparative Marker
Selection analysis. This analysis performs a two-sided
t-test. Genes were selected based on a Bonferroni-corrected
P value < 0.05. The data obtained has been deposited in
the NCBI Gene Expression Omnibus (GEO) database
according to the MIAME guidelines (accession number
GSE54015).
Gene ontology analysis
The GENECODIS (http://genecodis.cnb.csic.es) web-based
software tool was used to perform gene ontology (GO) en-
richment analysis [7,8]. The biological process and molecu-
lar functions were analysed simultaneously. Differentially
expressed genes that were common in the male and female
dataset were selected and were tested against the back-
ground set of all genes present in the Affymetrix GeneChip
Mouse Gene 1.0 STArray, using the default lowest GO an-
notation level. In addition, pathway enrichment analysis
based on the PANTHER (protein annotation through evo-
lutionary relationship) classification database (PANTHER
pathway) was used to identify significant pathways.
Real-time PCR
cDNA was synthesised using Bioscript™ Reverse Tran-
scriptase and random hexamers (Bioline Pty Ltd, Australia)
according to the manufacturer’s protocol. This was the
same RNA used for the microarrays. Quantitative PCR
(qPCR) was used to validate genes found to be differ-
entially expressed on microarray. Beta Actin (bAct), glyc-
eraldehyde 3-phosphate dehydrogenase (Gapdh), and
hypoxanthine guanine phosphoribosyl transferase (Hprt1)
were used as normalising genes (Additional file 1: Table
S1). Individual reactions (10 μl) contained 2× Sensifast
SYBR Mix (Bioline), forward and reverse primers (10 μM),
and 4 μl of cDNA (or 4 μl water for no template controls).
The PCR reactions were carried out in a MxPro3005P
Real Time PCR System (Stratagene, Agilent Technologies,
USA) followed by a dissociation curve. All samples were
run in triplicate.
Cycle threshold (Ct) values for each sample were cal-
culated using the MxPRo QPCR software (Stratagene,
Agilent Technologies, USA). Triplicate Ct values were
averaged and the quantity (Q) of each sample was calcu-
lated using the delta-delta Ct method. Q values from the
Table 1 Radiotelemetry measurements in 12 to 13 week






Male n = 6 n = 8
Systolic BP - Day (mmHg) 105.7 ± 1.8 133.5 ± 2.9 <0.001
Systolic BP- Night (mmHg) 114.2 ± 1.4 154.4 ± 4.2 <0.001
Systolic BP - 24 hr (mmHg) 109.9 ± 0.8 143.9 ± 4.0 <0.001
Diastolic BP - Day (mmHg) 78.2 ± 2.0 100.3 ± 3.2 <0.001
Diastolic BP - Night (mmHg) 87.0 ± 0.7 116.5 ± 3.3 <0.001
Diastolic BP - 24 hr (mmHg) 82.6 ± 0.6 108.4 ± 1.3 <0.001
Heart rate - Day (beats/min) 358.7 ± 13.8 518.1 ± 26.3 0.001
Heart rate - Night (beats/min) 438.5 ± 16.3 627.3 ± 5.0 <0.001
Heart rate - 24 hr (beats/min) 398.6 ± 5.2 572.7 ± 25.2 <0.001
Female n = 3 n = 4
Systolic BP - Day (mmHg) 112.1 ± 1.4 128.5 ± 1.5 0.008
Systolic BP- Night (mmHg) 117.6 ± 3.8 148.3 ± 1.6 0.009
Systolic BP - 24 hr (mmHg) 115.4 ± 3.6 138.4 ± 1.2 0.009
Diastolic BP - Day (mmHg) 93.4 ± 2.3 93.5 ± 2.1 0.98
Diastolic BP - Night (mmHg) 97.3 ± 6.6 111.7 ± 1.8 0.17
Diastolic BP - 24 hr (mmHg) 95.3 ± 3.6 102.6 ± 0.8 0.36
Heart rate - Day (beats/min) 486.8 ± 15.5 551.7 ± 9.7 0.018
Heart rate - Night (beats/min) 505.8 ± 21.1 677.7 ± 7.4 0.001
Heart rate - 24 hr (beats/min) 496.3 ± 11.2 614.7 ± 7.3 0.022
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metric means from these genes were used to generate a
normalisation factor (NF) [9]. The Q values of the genes
of interest were normalised by dividing by the NF value.
Statistical analysis
Results are expressed as mean ± standard error, or mean
fold changes in expression, and analysed using a general
linear model. Statistical analysis was performed with
PASW Statistics version 20. A P value of <0.05 was con-
sidered significant.
Results
Radiotelemetry was performed on male and female
BPH/2J and BPN/3J mice at 12 to 13 weeks of age. Male
BPN/3J and BPH/2J and female BPH/2J exhibited signifi-
cant differences in blood pressure and heart rate, be-
tween the day (inactive period) and night (active period),
with blood pressure and heart rate increased during the
night (active period). No differences in day and night
blood pressure or heart rate were seen in female BPN/3J.
In males, systolic arterial pressure, diastolic pressure and
heart rate were significantly higher in BPH/2J compared
with BPN/3J mice, regardless of time of day. In females,
BPH/2J mice had significantly higher systolic arterial
pressure and heart rate at both day and night when
compared to BPN/3J. However, no significant difference
in diastolic pressure was observed between BPH/2J and
BPN/3J females (Table 1). Within the BPH/2J strain no
significant difference in 24 hour systolic arterial pressure
or diastolic pressure or heart rate was observed between
males and females. In the BPN/3J strain, no difference in
24 hour systolic arterial pressure or diastolic pressure
was observed, however females had a significantly higher
24 hour heart rate (p = 0.02) when compared to males.
Microarray expression analysis was performed on both
male and female hypertensive (BPH/2J) and normoten-
sive (BPN/3J) mice. Comparison between BPH/2J and
BPN/3J was performed with male and female animals
analysed separately. In males, 348 genes were found to
be differentially expressed between BPH/2J and BPN/3J
(Additional file 2: Table S2). Of these, 170 were upregulated
and 178 were downregulated in the BPH/2J. In the females,
300 genes were found to be differentially expressed, with
152 upregulated and 150 downregulated in the BPH/2J
(Additional file 3: Table S3). Of the genes that were identi-
fied as being differentially expressed, 70 upregulated and
83 downregulated genes were common between males
and females.
Of the differentially expressed genes common in both
the male and female lists, GO enrichment analysis was
performed using GENECODIS [7,8] and biological pro-
cesses and molecular functions were examined. Single
categories that were significantly enriched in our geneset were transport (GO:0006810, p = 0.01), metabolic
process (GO:0008152, p = 0.019) and hydrolase activity
(GO:0016787, p = 0.038). In addition to these single
GO terms, a significant set of genes were co-annotated
with oxidation-reduction process and oxidoreductase ac-
tivity (GO:0055114, GO:0016491, p = 0.026) or metabolic
process and hydrolase activity (GO:0008152, GO:0016787,
p = 0.025). Panther Pathway enrichment analysis was also
performed and no pathways were found to be significantly
represented in our gene list.
Genes were selected for validation by qPCR (Table 2).
These genes were selected based on fold change differ-
ences, previous association with blood pressure regula-
tion, and/or involvement in processes or pathways that
may influence blood pressure. Of the genes that were
differentially expressed in both the male and female,
BPH/2J and BPN/3J comparisons, 15 out of 21 genes
(71%) were validated on qPCR. The expression of these
genes was also compared between males and females
within a strain (Table 3). The expression of Hdc, Edn3,
Il10rb, Gabra3a, Kcnk1, and Serpinb8 was significantly
higher in female kidneys compared to male kidneys in
both the BPH/2J and BPN/3J strains. Angplt7, Cndp2
and Cyp4b1 expression was significantly lower in females
when compared to males within a strain. The expression
of Pld1 and Pak6 was significantly higher only in BPH/2J















Hdc 1154 <0.001 1.86 5.0 <0.001 1.10
Gabra3 97 <0.001 1.53 128 <0.001 1.56
Angptl7 53 <0.001 1.47 89 <0.001 1.68
Cyp4b1 12.2 <0.001 1.15 20.4 <0.001 1.39
Edn3 4.4 <0.001 1.14 3.8 <0.001 1.16
Dna2 1.7 0.001 1.12 1.4 0.02 1.08
Cndp2 1.4 0.01 1.12 1.9 0.03 1.08
Mcm6 −10 <0.001 −1.30 −8.7 <0.001 −1.30
Vwa1 −10 <0.001 −1.23 −3.0 <0.001 −1.14
Kcnk1 −3.3 <0.001 −1.15 −3.2 <0.001 −1.18
Serpinb8 −2.5 <0.001 −1.21 −2.7 <0.001 −1.22
Pld1 −2.0 0.001 −1.11 −1.4 0.02 −1.11
Pter −1.7 0.001 −1.03 −1.5 <0.001 −1.03
Pak6 −1.7 <0.001 −1.10 −1.3 0.03 −1.11
Il10rb −1.3 0.004 −1.07 −1.3 0.01 −1.06
Values represent mean fold changes (FC) between BPH/2J and BPN/3J samples
relative to BPN/3J. Positive values indicate higher expression in BPH/2J samples
while, negative values indicate lower expression in BPH/2J samples.
Table 3 Quantitative PCR fold changes in females,
relative to males within a strain
BPH/2J BPN/3J
Gene FC P value FC P value
Hdc 1.7 <0.001 388 <0.001
Gabra3 1.6 0.005 1.2 0.01
Angptl7 −2.8 <0.001 −4.7 <0.001
Cyp4b1 −13.2 <0.001 −22.2 <0.001
Edn3 1.7 0.005 1.9 0.005
Dna2 1.0 0.17 1.2 0.99
Cndp2 −1.6 <0.001 −2.1 0.002
Mcm6 1.9 0.03 1.7 0.03
Vwa1 1.8 0.01 −1.5 <0.001
Kcnk1 1.9 <0.001 2.1 <0.001
Serpinb8 1.8 <0.001 1.8 0.001
Pld1 1.9 0.001 1.4 0.03
Pter 1.2 0.12 1.2 0.08
Pak6 1.3 0.01 1.1 0.38
Il10rb 1.6 <0.001 1.7 <0.001
Values represent mean fold changes (FC) between male and female samples
relative to males within a strain. Positive values indicate higher expression in
female samples while, negative values indicate lower expression in
female samples.
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lower only in the BPN/3J females. No difference in ex-
pression between the sexes within a strain was observed
for Mcm6, Dna2 or Pter.
Discussion
This study performed gene expression arrays in kidneys
of BPH/2J and BPN/3J male and female mice. It is the
first study to measure and compare gene expression pro-
files in female BPH/2J and BPN/3J mice to determine the
mechanisms involved in the development of high blood
pressure in these mice. The BPH/2J strain was generated
via multiple generations of brother sister mating selecting
for high blood pressure. Radiotelemetry in these mice
found significantly increased systolic arterial pressure in
both male and female hypertensive mice, compared with
the normotensive strain, with no difference in blood pres-
sure between males and females. This would suggest that
a common mechanism is responsible for high blood pres-
sure in both sexes. We found that while there were differ-
ences in the expression profiles between BPH/2J and
BPN/3J depending on sex, approximately half of the differ-
entially expressed genes were present in both male and fe-
male datasets. This allowed us to refine the list of possible
candidate genes that were only differentially expressed in
both sexes. This list included Angptl7, Hdc, Cndp2, Dna2,
Edn3, which were up-regulated in the hypertensive mice
and may have a physiological role in the regulation of high
blood pressure. Mcm6 and Il10rb were both down-
regulated in the hypertensive mice and may also play a
role high blood pressure. A previous study compared gene
expression across multiple tissues between 12 week old
male hypertensive and normotensive mice [3]. A number
of genes, including Angplt7, Hdc, Mcm6 and Il10rb that
were identified as being differentially expressed in the kid-
neys of those animals were also identified in the kidneys
of male and females in the current study.
We show that expression of this Angptl7 is increased
in BPH/2J kidneys, with expression being significantly
higher in male kidneys compared to females within a
strain. Angptl7 belongs to the angiopoietin like protein
family. Several angiopoietin-like proteins have been
shown to be involved in the regulation of angiogenesis
as well as lipid and glucose metabolism [10]. Angptl7 is
the least studied of all the angiopoietin-like proteins.
Studies in patients with glaucoma, a condition charac-
terised by increased intraocular pressure, have reported
elevated Angptl7 expression in the cornea [11]. Longitu-
dinal cohort studies have also shown hypertension is as-
sociated with an elevated risk of developing glaucoma
[12]. These studies, together with the increased expres-
sion of Angptl7 observed in the kidneys of our hyperten-
sive mice, suggests that Angptl7 may be upregulated in
response to increased vasculature pressure.
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genic hypertension and these mice have increased sym-
pathetic activity [4]. Histidine decarboxylase (Hdc) and
carnosine dipeptidase 2 (Cndp2) have been shown to be
involved in sympathetic activity. These genes are part of
the carosine- histidine - histamine metabolic pathway.
Carnosine is broken down into histidine via the action
of Cndp2, and then histidine is converted into histamine
by Hdc. Carnosine is an antioxidant that has been re-
ported to have a protective effect on kidneys as a scaven-
ger of reactive oxygen species [13]. It has been shown to
reduce renal sympathetic nerve activity in rats, and
inhibit hypertension in DOCA salt hypertensive rats
[14]. Additionally, a patient with congenital carnosinase
deficiency, the inability to breakdown carnosine, was
reported to have elevated levels of carnosine and
hypotension [15]. Cndp2 expression was significantly
elevated in both BPH/2J males and females. Elevated
levels of Cndp2 may result in reduced carnosine, de-
creased protection against oxidative stress, and increased
levels of histidine.
Hdc catalyses the conversion of histidine to histamine.
Histamine is a neurotransmitter that is involved in the
regulation of renal sympathetic activity and response to
inflammation. In anesthetised rats a low dose of hista-
mine suppressed renal sympathetic nerve activity and
blood pressure, while a high dose of histamine elevated
renal sympathetic nerve activity and blood pressure [16].
Hdc was previously reported to be significantly upregu-
lated in the kidneys of 12 week male BPH/2J [3]. It is
upregulated by estrogen and is expressed at higher levels
in female kidneys compared to males [17]. This was
reflected in our study, where the fold change between
male BPH/2J and BPN/3J was significantly larger than the
fold change between female BPH/2J and BPN/3J, due to
the BPN/3J males having low Hdc expression. Increased
expression of Cndp2 and Hdc may result in higher levels
of histamine in the BPH/2J animals which may contribute
to the elevated sympathetic activity and blood pressure
seen in this strain.
Genes that were involved in DNA replication, repair and
telomere maintenance were identified in both male and fe-
male datasets. Mcm6 is a subunit of the Mcm2-7 complex,
a replicative helicase that is involved in eukaryotic DNA
replication. It is an essential component of the MCM com-
plex as mutations in Mcm6 result in the loss of helicase
activity [18]. DNA2 is a nuclease/helicase that is essential
for Okazaki fragment processing during DNA replication.
Recent studies have also suggested a role for Mcm6 and
Dna2 in telomere length maintenance [19–21]. As telo-
mere length has been associated with hypertension [22],
dysregulation in the expression of these genes may affect
DNA replication and telomere maintenance may contrib-
ute the development of disease.A number of the differentially expressed genes in both
males and females were known to have links to blood pres-
sure regulation. Edn3 was identified as a candidate gene
for hypertension in humans via a GWA study [23]. The ex-
pression of Edn3 was found to be upregulated in BPH/2J
animals. Females were also found to have significantly
higher Edn3 expression when compared to males within a
strain. Increased expression of Edn3 in the kidneys of age-
ing rats has suggested that it may be a marker for advanced
ageing [24]. The prevalence of hypertension increases with
increasing age [25]. This may suggest a role for premature
ageing in hypertension.
Inflammation and oxidative stress are characteristic of
hypertension. IL10 is an anti-inflammatory cytokine that
can inhibit the synthesis of pro-inflammatory cytokines
[26]. It functions by binding to its receptor IL10R and acti-
vates JAK and STAT pathways. DNA variants in IL10rb, a
subunit of IL10R, have been associated with ischemic stroke
in individuals with hypertension [27], and IL10 deficiency
has been associated with preeclampsia, a condition charac-
terised by high blood pressure during pregnancy [28,29].
The reduced expression of IL10rb seen in both male and fe-
male BPH/2J mice may result in reduced IL10 activity and
increased inflammation in the hypertensive animals.
Many of the genes that were differentially expressed
between BPH/2J and BPN/3J also exhibited expression
differences between males and females within a strain.
These differences suggests that while a common mech-
anism is most likely responsible for high blood pressure
in the BPH/2J strain, differences in sex hormones will
influence how gene/pathways respond to elevated blood
pressure. Furthermore, these differences in expression
may help to explain the differences in disease phenotype
that are seen between men and women.
Conclusion
This study has identified a combination of potential new
candidate genes with no currently known links to hyper-
tension, as well as genes that had been previously associ-
ated with hypertension and blood pressure control. The
genes that we identified in both male and female BPH/2J
hypertensive mice may be involved in the development or
maintenance of hypertension. Our findings from the fe-
male dataset have helped to refine the possible pathways
that are involved in the onset of hypertension in these ani-
mals, as well as highlight potential mechanisms that may
explain the differences that are seen in the prevalence and
severity of hypertension between men and women.
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